Cetera Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,572
| Closed | -$389K | – | 1414 |
|
|
2022
Q2 | $389K | Sell |
7,572
-60
| -0.8% | -$3.08K | 0.01% | 953 |
|
|
2022
Q1 | $562K | Buy |
7,632
+254
| +3% | +$18.7K | 0.01% | 830 |
|
|
2021
Q4 | $1.06M | Buy |
7,378
+346
| +5% | +$49.5K | 0.02% | 580 |
|
|
2021
Q3 | $1.46M | Buy |
7,032
+309
| +5% | +$64.1K | 0.03% | 491 |
|
|
2021
Q2 | $1.43M | Buy |
6,723
+433
| +7% | +$91.9K | 0.03% | 436 |
|
|
2021
Q1 | $1.14M | Sell |
6,290
-1,961
| -24% | -$355K | 0.03% | 440 |
|
|
2020
Q4 | $920K | Buy |
8,251
+141
| +2% | +$15.7K | 0.03% | 441 |
|
|
2020
Q3 | $879K | Buy |
8,110
+2,190
| +37% | +$237K | 0.03% | 402 |
|
|
2020
Q2 | $493K | Buy |
+5,920
| New | +$493K | 0.02% | 535 |
|
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$11K | – | 1156 |
|
|
2019
Q1 | $11K | Buy |
+1,000
| New | +$11K | ﹤0.01% | 1130 |
|
|
2016
Q4 | – | Sell |
-750
| Closed | -$31K | – | 777 |
|
|
2016
Q3 | $31K | Buy |
+750
| New | +$31K | ﹤0.01% | 752 |
|